FDA accepts Dr. Reddy's biosimilar abatacept application for review

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/26/2026

1. SPY
2. AKAM
3. COST
4. META
5. ZS
6. NVDA
7. AWK
8. DRI
9. ULS
10. PRME

Go back to FDA accepts Dr. Reddy's biosimilar abatacept application for review
DR. REDDY'S LAB LTD ADR (NYSE: RDY) Delayed: 12.25 -0.05 (0.41%)
Previous Close $12.30    52 Week High $54.73 
Open $12.31    52 Week Low $40.68 
Day High $12.35    P/E N/A 
Day Low $12.17    EPS $0.00 
Volume 3,168,894